almost 2.5 million shares at 15.50, they bought several million shares of IDRA at 3.75 and they lost millions on XOMA .. They are no different than the average investor , they win some and they lose some.
you dont know that the result will be positive. although i hope it is i said if no positive news by tomorrow then
imo this will go bad. too close to deadline makes this riskier and riskier.
now is the time to buy imo. When BIIB was 480 it wasn't overvalued at 280 it is I strongly disagree..This
is one of the premier biotechs out there. Im surprised at this level no one has made a 325-350 bid for it. I don't care what fool says. imo under 300 is a nice buy. even the ceo bought 10k shares around 305 a nice
3 million dollar investment in his own company.
800k out of his pocket is peanuts. If he added 200k more down here than that would show a real confidence in his pipeline. He hasn't so like I said maybe just maybe things are not ducky. I find it
very troubling that with data so close this is $2+ from bust.